Steven K Galson Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

BCRX Quotes by TradingView

Steven K Galson is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 24,991 shares of BCRX, which is worth approximately $252,409. The most recent transaction as insider was on Jun 12, 2025, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25K
31.4% 3M change
31.4% 12M change
Total Value Held $252,409

Steven K Galson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2025
BUY
Grant, award, or other acquisition
-
12,500 Added 33.34%
24,991 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
6,820 Added 15.77%
36,431 Common Stock
May 13 2024
BUY
Open market or private purchase
$120,450 $5.49 p/Share
21,940 Added 29.85%
51,551 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
16,745 Added 36.12%
29,611 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
-
12,866 Added 50.0%
12,866 Common Stock
SKG

Steven K Galson

Director
Durham, NC

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCRX